Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study

被引：5
|
作者：
Qiang, Judy K. [1 ]
Shahbaz, Ali [2 ]
Kim, Whan [3 ]
Marinas, Joseph [3 ]
Greaves, Simon [4 ]
Yeung, Jensen [5 ]
机构：
[1] Univ Toronto, Fac Med, Toronto, ON M5S 1B2, Canada
[2] Univ Ottawa, Sch Med, Ottawa, ON K1N 6N5, Canada
[3] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1B2, Canada
[5] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON M5S 1B2, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2016年 / 74卷 / 01期
关键词：
TO-SEVERE PSORIASIS; ETANERCEPT; EFFICACY;
D O I：
10.1016/j.jaad.2015.08.030
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：176 / 177
页数：3
相关论文
共 50 条
  • [31] Real-World Effectiveness of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Canada
    Abu-Hilal, Mohannad
    Cowger, Jeff
    Bawazir, Mohammed
    Sajic, Dusan
    Savinova, Iryna
    Yap, Belinda
    El-Sayegh, Rami
    Bolatova, Talshyn
    Chan, Pak
    Cy, Ajith
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [32] Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series
    Ruiz-Villaverde, Ricardo
    Rodriguez-Fernandez-Freire, Lourdes
    Armario-Hita, Jose C.
    Perez-Gil, Amalia
    Galan-Gutierrez, Manuel
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (08) : 1029 - 1033
  • [33] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    Huang, He
    Cai, Ming-Long
    Hong, Xiao-Jie
    Zheng, Li-Jun
    Hu, Zhu-Lin
    Yuan, Tao
    Li, Wei-Ran
    Sheng, Yu-Jun
    Zhang, Xue-Jun
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 554 - 560
  • [34] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    He Huang
    Ming-Long Cai
    Xiao-Jie Hong
    Li-Jun Zheng
    Zhu-Lin Hu
    Tao Yuan
    Wei-Ran Li
    Yu-Jun Sheng
    Xue-Jun Zhang
    European Journal of Dermatology, 2020, 30 : 554 - 560
  • [35] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Hapa, Fatma Asli
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
  • [36] Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
    Schwarz, Christopher Willy
    Loft, Nikolai
    Rasmussen, Mads Kirchheiner
    Nissen, Christoffer, V
    Dam, Tomas Norman
    Ajgeiy, Kawa Khaled
    Egeberg, Alexander
    Skov, Lone
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [37] Discontinuation rates for biologic therapies in moderate-to-severe chronic plaque psoriasis in a real-world Canadian patient cohort
    Gulliver, S.
    Gulliver, W.
    Randell, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 34 - 34
  • [38] Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Zaaroura, Hiba
    Sachdeva, Muskaan
    Lu, Justin D.
    Rankin, Brian D.
    Prajapati, Vimal H.
    Vender, Ronald
    Yeung, Jensen
    JAAD INTERNATIONAL, 2022, 6 : 3 - 5
  • [39] Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
    Rigopoulos, Dimitrios
    Tampouratzi, Eleftheria
    Angelakopoulos, Charalampos
    Apalla, Zoe
    Barkis, Ioannis
    Georgiou, Sophia
    Delli, Florentina
    Drosos, Alexandros
    Zafiriou, Efterpi
    Katsantonis, John
    Lazaridou, Elisavet
    Panagakis, Pantelis
    Papadavid, Evangelia
    Papakonstantis, Markos
    Roussaki-Schulze, Angeliki-Viktoria
    Sotiriou, Elena
    Anastasiadis, Georgios
    Chasapi, Vasiliki
    Sfaelos, Konstantinos
    Ioannides, Dimitrios
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (06) : 1121 - 1130
  • [40] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
12345